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A plaque variant of SV40 that was first isolated in the 1960s, designated SV40-LP(KT), was molecularly cloned and subjected to sequence
analysis. The genome of SV40-LP(KT) was found to be nearly identical to the previously described isolate known as 777. However, SV40-LP
(KT) contained a mutation in the VP1 coding region resulting in a change of histidine 136 to tyrosine. This VP1 mutation was identified as a
genetic determinant influencing a number of phenotypes associated with SV40-LP(KT) such as plaque morphology, intracellular vacuole
formation, and ganglioside receptor usage.
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Polyomaviruses are small, non-enveloped viruses with
double-stranded, circular DNA genomes of approximately
5000 base pairs that have been found in numerous species of
birds and mammals (Imperiale and Major, 2007). The major
structural protein VP1 of the polyomavirus SV40 assembles
into 72 pentamers that form the icosahedral capsid (Liddington
et al., 1991; Stehle et al., 1996). The VP1 pentamer forms a
barrel-like structure around a conical hollow with its wider
opening towards the interior of the virus (Stehle et al., 1996).
This hollow accommodates one of the two minor capsid
proteins, either VP2 or VP3. Thus, for the intact virus particle,
VP2 and VP3 remain largely sequestered within the capsid,
while the surface residues of VP1 provide the primary
functional contacts between the virus particle and its environ-
ment. These general structural features are conserved among all
polyomaviruses (Stehle et al., 1994).⁎ Corresponding author. Building 29A, Room 1B10, CBER, FDA, 29 Lincoln
Drive, Bethesda, MD 20892, USA. Fax: +1301 496 1810.
E-mail address: andrew.lewis@fda.hhs.gov (A.M. Lewis).
0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2007.08.040A key interaction between the virus particle and its host
occurs during virus entry into cells. The capsid must interact
with specific receptors on the cell surface that allow subsequent
endocytosis of the virus particle. Early studies identified the
class I major histocompatibility complex (MHC) protein as a
receptor for SV40 (Atwood and Norkin, 1989; Breau et al.,
1992). However, class I MHC does not appear to be the sole
determinant of infectivity and tropism as the expression of class
I MHC does not strictly correlate with the ability of the virus to
bind to the cell surface (Basak et al., 1992; Breau et al., 1992).
Recently, the ganglioside GM1 has been shown to mediate the
entry of SV40 into cells. A rat cell line deficient in ganglioside
synthesis can display exogenously supplied gangliosides on the
cell surface; supplying such a cell with GM1 greatly facilitates
SV40 infection (Tsai et al., 2003). Other polyomaviruses also
use specific gangliosides for cell entry. For example, the
ganglioside GT1b is used by both BK virus and murine
polyomavirus (Low et al., 2006; Tsai et al., 2003).
The features on the surface of SV40 that interact with cellular
receptors are unknown. The crystal structures of murine
polyomavirus complexed with small sialic acid-bearing carbo-
hydrate ligands have been determined (Stehle and Harrison,
Table 1
Sequence comparison: 777 vs. SV40-LP(KT) and 777⁎ vs. SV40-LP(KT)
SV40 region 777 vs. SV40-LP(KT) 777⁎ vs. SV40-LP(KT)
Nucleotide change a Amino acid change Nucleotide change b Amino acid change
Regulatory region Complex arrangement of 72 bp enhancer Not applicable No change Not applicable
Late region 1841 (C→T) VPI HI36→Y 741 (C→T) VP2 T63→S
937 (T→C) Silent
1905 (C→T) VP1 H136→Y
a Nucleotide number according to 777 (AF332562) sequence.
b Nucleotide number according to 777* (AY271817) sequence.
344 H. Murata et al. / Virology 370 (2008) 343–3511996, 1997; Stehle et al., 1994), but similar data are not
available for SV40 and related human polyomaviruses (JC virus
and BK virus). The identification of surface amino acid residues
on polyomavirus capsids that function in critical aspects of the
virus life cycle, such as cell entry, can be exploited in a number
of ways. For example, detailed capsid structure/function data
should facilitate the development of serological assays with
enhanced specificity that more effectively discriminate among
polyomaviruses than existing assays.
In this communication, we report the whole-genome se-
quence analysis of an SV40 plaque variant that we have
designated as SV40-LP(KT). This isolate is closely related to
previously identified isolate 777. The structural basis for several
novel phenotypes associated with SV40-LP(KT) resides in a
point mutation that alters a single amino acid in the capsid
protein VP1. It is of particular interest that a virus bearing this
VP1 mutation appears to be deficient in its ability to interact
with the ganglioside GM1.
Results
Sequencing of SV4-LP(KT)
A large plaque variant of SV40 that we designate as SV40-LP
(KT) was obtained from K. Takemoto, National Institutes ofFig. 1. Plaque morphology in CV-1 and primary African green monkey kidHealth (Takemoto et al., 1966); Takemoto originally referred to
this isolate as SV40-L. We have amended the designation to
reflect its source. The genome of SV40-LP(KT) wasmolecularly
cloned and subjected to sequence analysis. The sequence com-
parisons between SV40-LP(KT) (GenBank accession number
EF579803) and two previously reported isolates of strain 777 are
summarized in Table 1. SV40-LP(KT) differed from the se-
quence designated 777 (GenBank accession number
AF332562) in only two ways: (1) SV40-LP(KT) contained a
complex, non-archetypal arrangement in the regulatory region
of the genome (an imperfect duplication with approximately
two incomplete copies of the 72 base pair enhancer), whereas
777 has an archetypal regulatory region (containing a single
copy of the enhancer); and (2) SV40-LP(KT) contained a single
nucleotide alteration in the late region of the genome resulting
in a coding change for the structural protein VP1 (histidine 136
altered to a tyrosine). In comparison with the 5244 base pair
genome sequence termed 777⁎ (GenBank accession number
AY271817), an isolate recovered from a rodent cell transformed
by 777 (Forsman et al., 2004), the 5244 base pair sequence of
SV40-LP(KT) differed by only 3 nucleotides, all found in the
late region of the genome (Table 1); one of the three differences
reflected the previously mentioned VP1 H136→Y change.
Notably, the regulatory region of SV40-LP(KT) was identical to
that of 777⁎.ney (pAGMK) cells. Plaques were visualized at 14 days post-infection.
Fig. 2. Vacuolization phenotype in CV-1 cells. Confluent monolayers of cells grown in T75 flasks were inoculated with 105 pfu of the indicated virus. Phase-contrast micrographs were taken at 200× magnification on
post-infection day 6 through day 9.
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Fig. 3. Transmission electron micrographs of infected CV-1 cells. Confluent cells grown in 24-well culture plates were infected with 50,000 pfu/well of the indicated virus. At day 6 post-infection, the samples were fixed
and prepared for electron microscopy as described in Materials and methods. (A) A cell infected by 776 at 1600× magnification. (B) A higher magnification (20,000×) of the same cell shown in panel A. (C) A cell
infected by 776 at a later stage of infection at 1600× magnification. (D) A higher magnification (20,000×) of the same cell shown in panel C. (E) A cell infected by 776 VP1 H136→Y at 1600× magnification. (F) A
higher magnification (20,000×) of the same cell shown in panel E. (G) A cell infected by 776 VP1 H136→Yat a later stage of infection at 1600× magnification. (H) A higher magnification (20,000×) of the same cell
shown in panel G.
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347H. Murata et al. / Virology 370 (2008) 343–351VP1 His136→Tyr mutation influences plaque morphology
The original assignment of SV40-LP(KT) as a large-plaque
variant is based on its behavior in primary African green monkey
kidney cells. However, in the CV-1 cell line (derived from
African green monkey kidney cells), SV40-LP(KT) produces
small plaques (Takemoto et al., 1966, 1968). We sought to
determine whether or not the H136→YVP1mutation occurring
in SV40-LP(KT) could explain this unusual plaque phenotype
by introducing this mutation into the 776 strain background. As
shown in Fig. 1, both SV40-LP(KT) and the 776 VP1 H136→Y
mutant produced ∼1 mm diameter plaques in CV-1 cells,
whereas the parental 776 virus produced 3–5 mm plaques. In
contrast, the plaques produced by the 776 VP1 H136→Y
mutant in primary African green monkey kidney cells were
similar to SV40-LP(KT) plaques (5–10 mm plaques) and were
larger than those produced by 776 (3–5 mm plaques). TheseFig. 4. (A) Plaque assays performed in the absence (control) or presence of soluble ga
ganglioside prior to inoculation of cells. Plaques were visualized at 14 days post-infe
the inoculum was approximately 130 pfu/dish. (B) Quantification of plaques from th
8 dishes per group are shown. The value obtained in the control group (in the absenresults demonstrate that the cell type-dependent plaque behavior
of SV40-LP(KT) is conferred by the H136→Y change alone
and is independent of other genetic differences between SV40-
LP(KT) and 776. Despite having different plaque phenotypes in
CV-1 cells, the titers of 776 and 776 VP1 H136→Yproduced in
CV-1 cells were comparable and typically greater than 107 pfu/
mL (data not shown). This suggests that the VP1 mutation has
minimal effect on replication efficiency in these cells.
VP1 His136→Tyr mutation confers a minimal vacuolization
phenotype
During the course of studying SV40-LP(KT), we noticed
that this isolate exhibited a hitherto unreported cytopathic
phenotype. SV40 typically induces a distinctive cytopathology
that involves the extensive formation of intracellular vacuoles
(Sweet and Hilleman, 1960). In the experiment shown in Fig. 2,ngliosides (GM1 and GT1b). Viruses were incubated with 5 μM of the indicated
ction. For 776, the inoculum was approximately 70 pfu/dish; for 776 H136→Y,
e experiment shown in panel A. The means (with 95% confidence intervals) of
ce of ganglioside) was used for normalization.
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inoculated with 105 pfu of the indicated virus (SV40-LP(KT),
776, or 776 VP1 H136→Y). SV40 776 induced detectable
cytopathic effect (CPE) in CV-1 cells starting at day 4 post-
infection. By day 6, most of the cells were extensively
vacuolated. In contrast, SV40-LP(KT) produced a relatively
nondescript CPE with very few vacuolated cells, and when
vacuoles occurred, they tended to be smaller and less noticeable
than those produced by 776. The 776 VP1 H136→Y mutant
behaved in a manner similar to SV40-LP(KT) (Fig. 2). Thus, the
VP1 H136→Y mutation appears to be sufficient to confer what
we have termed a “minimal vacuolization” phenotype. The data
suggest that a determinant of the vacuolization phenotype of
SV40 maps to VP1. For all viruses, CPE was nearly complete
by day 9 post-infection. Similar results were obtained with
experiments using primary African green monkey kidney cells
(data not shown). Thus, this phenomenon appears to be
controlled by the virus rather than the host cell.
VP1 His136→Tyr mutation diminishes the interaction between
virus particles and intracellular membranes
The possibility that a structural protein of SV40 might be
involved in the formation of cytoplasmic vacuoles prompted us
to visualize the relationship between virus particles and
intracellular membranes through transmission electron micros-
copy. CV-1 cells were infected with 776 or 776 VP1 H136→Y
and fixed for analysis at a late stage of CPE. Most of the cells
infected by 776 were vacuolated; a typical cell is shown in
Fig. 3A. Examination of the same cell at a higher magnification
(Fig. 3B) revealed that the nucleus was filled with virus
particles. However, relatively few particles were located in the
cytoplasm, and their interaction with vacuolar membranes was
not obvious. Occasionally, a cell at an even later stage of CPE
was encountered (Fig. 3C). Even though the overall architecture
of such a cell appeared intact, cell permeabilization had
occurred to some extent as evidenced by a noticeable loss of
intracellular electron density (compare Figs. 3A and C). Virus
particles were abundant throughout the cytoplasm of such a cell
and consistently appeared to array in close apposition toFig. 5. VP1 histidine 136 (side chain depicted in red) resides in a surface loop. Two vie
software (National Center for Biotechnology Information; Bethesda, MD) based onintracellular membrane surfaces (Fig. 3D). The tendency of
SV40 to align on membranous structures was reported in earlier
electron micrographic studies (Granboulan et al., 1963; Oshiro
et al., 1967). This non-random distribution suggests that the
SV40 particle has an intrinsic affinity for membranes (or some
constituent of membranes). As expected, a cell infected by 776
VP1 H136→Y contained few vacuoles (Fig. 3E). Examination
of the same cell at a higher magnification revealed a nucleus
filled with virus particles; cytoplasmic particles were rather
sparse (Fig. 3F). Again, cytoplasmic particles were observed in
abundance only in cells that were somewhat permeabilized (Fig.
3G). However, the mutant particles did not appear to associate
with intracellular membranes to the same extent as 776 particles
(compare Figs. 3D and H).
VP1 His136→Tyr mutation confers resistance to inhibition by
soluble ganglioside GM1
A critically important interaction between SV40 particles and
cellular membranes occurs at the cell surface during virus entry.
Recent studies have identified the ganglioside GM1 as a receptor
for SV40 (Tsai et al., 2003). We performed plaque assays in CV-
1 cells in the absence or presence of soluble gangliosides. When
GM1 was present in the inoculum at a concentration of 5 μM,
776 plaque formation was inhibited by 4.3-fold. In contrast,
plaque formation by 776 VP1 H136→Y was not significantly
affected under the same conditions (Figs. 4A and B). The
ganglioside GT1b, which can serve as a receptor for both mouse
polyomavirus as well as BKV (Low et al., 2006; Tsai et al.,
2003), had no significant effect on the plaque-forming efficiency
of 776 or 776 VP1 H136→Y; thus, differential inhibition ap-
pears to be specific to GM1.
Discussion
The novel VP1 H136→Y variation harbored by SV40-LP
(KT) influences several phenotypes including plaque morphol-
ogy, vacuolization, intracellular membrane attachment, and
resistance to inhibition by soluble ganglioside GM1. Histidine
136 is situated in the surface DE loop of VP1 and guards thews of the SV40 pentamer are shown. The images were generated using the Cn3D
structural data deposited by Stehle et al. (1996).
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with the main axis of symmetry (Fig. 5) (Liddington et al.,
1991; Stehle et al., 1996). This cavity, or surface features in its
vicinity, might contain one or more binding sites for cellular
factors that function as mediators in the manifestation of the
aforementioned phenotypes.
One such factor may be the ganglioside GM1. Our data
suggest that the DE loop of VP1 may be directly interacting
with GM1. A recent study demonstrated that delivery of gangli-
oside GM1 to C6 rat glioma cells facilitates virus cell entry and
large T-antigen expression; this enhancement is competitively
inhibited when infection occurs in the presence of soluble
GM1 (Tsai et al., 2003). To our knowledge, our study is the
first demonstration that GM1 might also play a role in the
infection of a simian cell type normally permissive to infection
by SV40.
Although clarification will require the identification of other
SV40 VP1 mutants, we speculate that the common denominator
that underlies the varied phenotypic observations examined in
our study may, in fact, be the interaction between the virus
particle and ganglioside GM1. Murine polyomavirus VP1 mu-
tants provide precedence for this idea. A small plaque (SP)
strain of murine polyomavirus has a substantially higher affinity
for branched disialyl receptor structures than a large plaque (LP)
strain (Cahan et al., 1983). This difference in receptor
interaction maps to a single amino acid change in VP1 at
amino acid residue 92 in the BC loop (glutamate for LP and
glycine for SP) (Freund et al., 1991). By analogy, the SV40 VP1
H136→Yalteration, which apparently reduces interaction with
GM1, also clearly influences plaque morphology. Even our
observation that the VP1 H136→Y mutant virus particle
attaches to a lesser extent to intracellular membranes might be
indicative of decreased binding to gangliosides (and related
sugar moieties) contained in those membranes. However, we
typically observe that 776 virus particles decorate the
cytoplasmic surface of internal membranes. Carbohydrates in
the form of glycolipids and glycoproteins are normally found in
the lumenal surface of biosynthetic compartments. A possible
explanation for this topological inconsistency can be found in a
recent study demonstrating that SV40 structural proteins have
intrinsic membrane-permeabilizing activity (Daniels et al.,
2006); membrane permeabilization might allow the virus
particles to access and bind sugar moieties exposed on the
lumenal face of intracellular membranes. The permeabilized
nature of the cells that exhibit virus-to-membrane attachment is
consistent with this possibility.
We have found what appears to be a novel vacuolization
phenotype associated with the VP1 H136→Y mutation.
Vacuolization has been considered a hallmark of the cytopathol-
ogy induced by SV40; in fact, early reports refer to SV40 as the
“vacuolating agent” (Sweet and Hilleman, 1960). However, the
mechanism that produces cytoplasmic vacuoles is not under-
stood. Our data suggest that VP1 might be a determinant of the
vacuolization phenotype. However, transmission electron
micrographs demonstrate that vacuoles occur at a stage of
infection when relatively few virus particles are localized in the
cytosol. It is possible that VP1 monomers or pentamers (whichare not readily visible by electron microscopy), rather than
assembled particles, might be the direct mediators involved in
the morphogenesis of cytoplasmic vacuoles. Alternatively, VP1
might produce vacuoles via an indirect mechanism (i.e.,
initiation of a signaling event leading to vacuole formation).
Summary
We report the complete genomic sequence of SV40-LP(KT)
and describe the phenotypic properties of a viable SV40 mutant
harboring a single amino acid change in VP1 that is found to
occur in SV40-LP(KT). The mechanism of cell entry by SV40
and related polyomaviruses is an actively investigated subject
(Pelkmans et al., 2001). The VP1 mutant virus that we have
characterized might be a useful tool to study the dependence of
SV40 endocytosis on gangliosides. Furthermore, a mutation that
alters receptor usage would also be expected to influence
tropism; thus, it might be possible to exploit this mutation in the
development of SV40-based gene therapy vectors (Strayer et al.,
2005).
Materials and methods
Cells and virus stocks
SV40 large plaque (SV40-LP(KT)) was obtained from K.
Takemoto, National Institutes of Health (Takemoto et al., 1966);
the stock bottle was dated 1965. CV-1 cells were obtained from
the American Type Culture Collection (Manassas, Virginia).
Primary African green monkey kidney cells were obtained from
Diagnostic Hybrids (Athens, Ohio). All cells were grown in
DMEM supplemented with 10% fetal bovine serum (HyClone;
Logan, Utah) and 4 mM glutamine. A working stock of SV40-
LP(KT) was generated by inoculating 0.5 mL of Takemoto's
original stock into a confluent T75 flask of primary African
green monkey kidney cells.
Cloning of SV40-LP(KT)
Confluent flasks of primary African green monkey kidney
cells were infected with 0.5 mL of Takemoto's original stock of
SV40-LP(KT). Cells were harvested when CPE was∼1+SV40
genomic DNA was isolated according to the method of Hirt
(Hirt, 1967; Peden et al., 1980). Hirt DNA was digested with
BamHI and cloned into BamHI-digested pBluescript; the
resulting construct was referred to as pSV-LP.
Sequencing of SV40
Sequencing of cloned SV40 was performed using Big Dye
Terminator version 3.1 and an ABI Prizm 3100 machine. The
sequencing primers are described elsewhere (Peden, et al. in
press). For sequencing the SV40-LP(KT) genome, primers were
spaced ∼400 nucleotides apart on both strands; sequence
coverage was minimally three-fold throughout the genome. The
genomic sequence for SV40-LP(KT) was submitted to
GenBank and assigned the accession number EF579803.
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pUC19 was digested with BamHI and HindIII in the multiple
cloning site, and the vector fragment was blunt-ended and re-
circularized; the resulting vector, termed pHM1, was disrupted
for all restriction sites between (and including) BamHI and
HindIII. The SV40 776 genome from pSV-B3 (Peden et al.,
1980) was excised by restriction digest with BamHI, re-ligated
to circles, and digested and cloned into pHM1 using the
restriction enzyme Asp718 (an isoschizomer of KpnI); the
resulting construct was named pSV776.1. Site-directed muta-
genesis of pSV776.1 to introduce the VP1 His136→Tyr
mutation was performed using the QuikChange XL Kit
(Stratagene; La Jolla, CA); the resulting mutant construct,
pSV776.VP1.1, was sequenced in the relevant region to verify
the presence of the mutation.
Generation of infectious SV40 by transfection of cloned
SV40 DNA
Two micrograms of cloned SV40 DNA (pSV-LP, pSV776.1,
or pSV776.VP1.1) was digested with the cloning enzyme
(either Asp718 or BamHI) and re-ligated to circles. The ligation
reaction was transfected into CV-1 cells using the PolyFect
reagent (Qiagen; Valencia, CA) according to the manufacturer's
protocol. The monolayer was lysed within 10 days. The lysate
was frozen and thawed three times, subjected to low speed
centrifugation (∼200 RCF for 5 min) to remove debris, and
stored frozen at −20 °C until use.
Transmission electron microscopy
CV-1 cells were plated in 24-well tissue culture plates.
Confluent cells were inoculated with 50,000 pfu of virus per
well. At 6 days post-infection, samples were fixed overnight at
4 °C with 2.5% glutaraldehyde in isotonic Millonig's phosphate
buffer pH 7.4. Following washes with Millonig's phosphate
buffer, the samples were post-fixed with 1% osmium tetroxide
in Millonig's phosphate buffer for 1 h and stained with 2%
uranyl acetate for 1 h. The samples were then dehydrated in a
graded series of ethanol solutions. After embedding in Epon
812, the samples were sectioned to 600–800 Å thickness with a
Reichert Ultracut E ultramicrotome. Thin sections were
mounted on copper grids and stained with 0.4% lead citrate
for 1.5 min. The grids were examined using a Zeiss EM10 CA
transmission electron microscope.
Plaque assay
Plaque assays were performed using CV-1 cells or primary
African green monkey kidney cells. Confluent cells grown in
60-mm dishes were infected with dilutions of virus made in
culture medium (1 mL inoculum/dish). Following incubation at
37 °C for 1 h, the inoculum was removed, and an overlay (4 mL)
of modified Eagle's medium with 5% fetal bovine serum, 4 mM
glutamine, and 0.75% Difco Noble agar was added. Fresh
overlay (3 mL) was added on day 4 and day 8. An overlay(2 mL) containing neutral red at a final concentration of 50 μg/
mL was added on day 13. Plaques were assessed on day 14. In
order to make plaques more visible, the overlay was routinely
stripped, and the cells were fixed with methanol and stained
with crystal violet (0.04%). In experiments involving neutral-
ization with gangliosides, stock solutions of gangliosides (GM1
and GT1b) obtained from Sigma (St. Louis, Missouri) were
prepared in ethanol at a concentration of 1 mM. Equal volumes
of virus dilution and 10 μM ganglioside solution (prepared by
diluting into culture medium) were mixed and incubated at
37 °C for 15 min; thus, the final concentration of ganglioside
was 5 μM. One milliliter of the mixture was added to each 60-
mm dish of CV-1 cells. From this point, plaque assays were
carried through as described above.
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